Issue link:

Contents of this Issue


Page 38 of 42

News on R&D and progress in the treatment of respiratory diseases, such as asthma and COPD. Calendar: The industry organizations page of the Inhalation website provides descriptions and contact information for cross-industry organizations and groups that present educational conferences and workshops. Inhalation OctOber 2023 37 2021 and includes relocation of existing labs from other parts of the Renaissance campus nearby to a new, 31,000 square foot science building and office space, which opened in 2022. e changes are part of an overall renovation and expansion in Renaissance's main campus, which will include a total of four buildings by the first quarter of 2024. "ese laborato- ries were built with our clients in mind, providing ample space for growth and the infrastructure to be able to continue to grow in the future," said Serge Maltais, presi- dent and CEO. RESPIRATORY MEDICINE NEWS Rapid test could determine existence of eosinophils HAMILTON, ONTARIO, CAN- ADA—According to News- Medical. Net, researchers from McMaster University and St. Joseph's Health- care Hamilton have developed a simple test that can rapidly and accurately identify the presence of eosinophils by tracking their pro- tein signatures, even when they are present in complex biological sam- ples such as sputum. e test looks similar to the COVID-19 home test, which could make it adapt- able to mass manufacturing, if approved for clinical use. To create the test, the researchers developed a DNAzyme. First isolated in 1994, protein-targeting DNAzymes have primarily been generated for detec- tion of metals or bacterial targets. e researchers believe that, until now, no one had succeeded in using DNAzymes to target specific protein markers in any context. e team was led by John Brennan, director of McMaster University's Biointer- faces Institute and Parameswaran Nair, a professor and respiratory physician at St. Joseph Healthcare Hamilton's- based Firestone Insti- tute for Respiratory Health and professor of medicine at McMas- INDUSTRY NEWS continued from page 8 ter University. Nair explained that a rapid test to detect eosinophilia could help clinicians make decisions about using drugs such as steroids or new biologics for patients with severe asthma and other lung dis- eases associated with eosinophilia, such as severe cough, and COPD. It could also help limit the unnec- essary use of antibiotics. Next, the researchers are planning a clinical trial. Findings were published in Angewandte Chemie. CALENDAR Please visit the industry organi- zations page of the Inhalation website to find descriptions and contact information for cross- industry organizations and groups that present educational confer- ences and workshops. industry-organizations

Articles in this issue

Links on this page

view archives of Inhalation - INH1023